Another baby formula shipment from Europe to arrive in the U.S. on Wednesday

Another baby formula shipment from Europe to arrive in the U.S. on Wednesday


Empty shelves show a shortage of baby formula at a Target store in San Antonio, Texas, May 10, 2022.

Kaylee Greenlee Beal | Reuters

FedEx Express has secured a government contract to bring another shipment of infant formula to the U.S. on Wednesday, NBC News reported.

The Express plane will fly Nestlé baby formula from Ramstein Air Base in Germany to Dulles International Airport near Washington, D.C. From there, the formula will be transported to a Nestlé facility in Pennsylvania. It’s unclear how much formula the plane will carry.

The move is meant to address a critical shortage of baby formula in the United States after top formula maker Abbott Laboratories closed a manufacturing plant following reports of bacterial infections in four infants.

Abbott said it would take about two weeks to reopen the plant and up to eight weeks for products to hit the shelves nationwide. That’s left a wide gap for scores of parents across the nation.

In an effort to ease the burden, the Food and Drug Administration is increasing baby formula imports from other countries. Dubbed “Operation Fly Formula,” the first shipment, carrying 78,000 pounds of specialty infant formula, arrived Sunday.

President Joe Biden has also invoked the Defense Production Act to increase baby formula manufacturing. His administration is seeking to stock shelves with 1.5 million containers of Nestle specialty infant formula.



Source

Healthy Returns: Chinese obesity drug emerges as a potential rival to Eli Lilly’s Zepbound
Health

Healthy Returns: Chinese obesity drug emerges as a potential rival to Eli Lilly’s Zepbound

Cr | Istock | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Another potential competitor to blockbuster obesity treatments from Eli Lilly and Novo Nordisk just showed positive data – but this time, […]

Read More
FDA to consider drug affordability when granting new vouchers to speed up approvals, Makary says
Health

FDA to consider drug affordability when granting new vouchers to speed up approvals, Makary says

The Food and Drug Administration will consider drug affordability when granting companies new vouchers that speed up approvals of some treatments, the agency’s Commissioner Marty Makary told CNBC on Friday.  The FDA in June announced a national priority voucher plan that aims to cut drug review times to one-to-two months for companies it says are […]

Read More
Hims & Hers to offer generic semaglutide in Canada as Novo Nordisk patent lapses
Health

Hims & Hers to offer generic semaglutide in Canada as Novo Nordisk patent lapses

The Hers website arranged on a laptop in New York, US, on Wednesday, Feb. 12, 2025. Gabby Jones | Bloomberg | Getty Images Hims & Hers Health announced Wednesday it will offer generic semaglutide in Canada as Novo Nordisk‘s patent on its branded drugs Ozempic and Wegovy is set to expire in January. “Canada is […]

Read More